Sign in or Register   Sign in or Register
  |  

Mouse Anti-EIF3I Recombinant Antibody (3B10) (CBMAB-A2532-LY)

The product is antibody recognizes EIF3S2. The antibody 3B10 immunoassay techniques such as: WB, ELISA.
See all EIF3I antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
3B10
Antibody Isotype
IgG2a, κ
Application
WB, ELISA

Basic Information

Immunogen
EIF3S2 (NP_003748.1, 226 a.a. ~ 325 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Eukaryotic Translation Initiation Factor 3 Subunit I
Entrez Gene ID
8668
UniProt ID
Q13347
Alternative Names
EIF3S2; PRO2242; TRIP-1; TRIP1; eIF3-beta; eIF3-p36
Research Area
Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815).

The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632).

The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773).
Biological Process
Cytoplasmic translational initiation Source: GO_Central
Formation of cytoplasmic translation initiation complex Source: UniProtKB-UniRule
Translational initiation Source: UniProtKB
Cellular Location
Cytoplasm
PTM
Phosphorylated by TGF-beta type II receptor.

Kuai, L., Xiang, Y. W., Chen, Q. L., Ru, Y., Yin, S. Y., Li, W., ... & Li, B. (2022). PD-L1 Triggered by Binding eIF3I Contributes to the Amelioration of Diabetes-Associated Wound Healing Defects by Regulating IRS4. Journal of Investigative Dermatology, 142(1), 220-231.

Lin, Z., Shen, D., Yang, B., & Woo, C. M. (2022). Molecular and structural characterization of lenalidomide-mediated sequestration of eIF3i. bioRxiv.

Ma, S., Dong, Z., Cui, Q., Liu, J. Y., & Zhang, J. T. (2021). eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis. Cancer Letters, 500, 11-20.

Krassnig, S., Wohlrab, C., Golob-Schwarzl, N., Raicht, A., Schatz, C., Birkl-Toeglhofer, A. M., ... & Haybaeck, J. (2021). A profound basic characterization of eIFs in gliomas: Identifying eIF3I and 4H as Potential novel target candidates in glioma therapy. Cancers, 13(6), 1482.

Roobol, A., Roobol, J., Smith, M. E., Carden, M. J., Hershey, J. W., Willis, A. E., & Smales, C. M. (2020). Engineered transient and stable overexpression of translation factors eIF3i and eIF3c in CHOK1 and HEK293 cells gives enhanced cell growth associated with increased c-Myc expression and increased recombinant protein synthesis. Metabolic engineering, 59, 98-105.

Llácer, J. L., Hussain, T., Dong, J., Gordiyenko, Y., & Hinnebusch, A. G. (2020). eIF3b and eIF3i relocate together to the ribosomal subunit interface during translation initiation and modulate start codon selection. bioRxiv, 453688.

Xiao, W., Zhang, W., Huang, H., Xie, Y., Zhang, Y., Guo, X., ... & Song, X. (2019). Cancer targeted gene therapy for inhibition of melanoma lung metastasis with eiF3i shRNA loaded liposomes. Molecular Pharmaceutics, 17(1), 229-238.

Chai, R. C., Wang, N., Chang, Y. Z., Zhang, K. N., Li, J. J., Niu, J. J., ... & Wang, Y. Z. (2019). Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma. Cancer Cell International, 19(1), 1-13.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-EIF3I Recombinant Antibody (3B10)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare